Sector: Pharmaceuticals & Biotechnology

Small Cap

CCME Global Share Price

Q: What is the Market Capitalization of CCME Global Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 28 April 2025, the market cap for CCME Global Ltd. is approximately ₹ 140.3 Cr.

Q: What are the PE and PB ratios for CCME Global Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for CCME Global Ltd. is -196.3, and the Price-to-Book (PB) ratio is 17.9.

Q: What is the 52-Week High and Low for CCME Global Ltd.?

Over the past 52 weeks, the highest price reached by CCME Global Ltd. shares was ₹ 184.9, and the lowest price was ₹ 21.22.

Q: Who are the major shareholders of CCME Global Ltd.?

Significant shareholdings in CCME Global Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of CCME Global Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, CCME Global Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

CCME Global Ltd.

₹107.90

5.10(4.96%)

Trade Now

No Graph

NSE :

Open Free Demat Account

CCME Global Performance

Price Movement

N/A

₹107.50

₹107.90

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹107.90

Low₹107.50

Open at₹107.90

Prev Close₹102.80

Volumes384

Avg Price₹107.61

Lower Circuit₹102.55

Upper Circuit₹113.25

Historical Performance

3M High₹130.10

3M Low₹73.90

1 Yr High₹184.90

1 Yr Low₹21.22

3 Yr High₹184.90

3 Yr Low₹9.73

5 Yr High₹184.90

5 Yr Low₹7.46

Summary

As of 18-06-2026 07:05, CCME Global Ltd. share price today is ₹0, with a change of ₹-102.80 (-100.00%) from the previous close of ₹102.8. The stock opened at ₹107.9 and traded between ₹107.5 and ₹107.9, with a total traded volume of 384 shares. The company has a market capitalization of ₹140.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹184.9 and ₹21.22, respectively.

CCME Global Ltd. valuation metrics include a P/E ratio of -196.3, and book value of ₹17.90. Profitability indicators show ROE of -1.78%. CCME Global Ltd. has reported net profit of ₹-0.71 Cr.

CCME Global Ltd. technical indicators include Day RSI at 55.9, Day MFI at 57.82, Day ADX at 22.34. Additional indicators include Commodity Channel Index (CCI) at 3.1 and Williams %R at -50.4. Momentum indicators show Day MACD at 0.72, Day MACD Signal Line at 2.07, DayATR at 5.64. Rate of Change indicators for CCME Global Ltd. include ROC125 at -41.64 and ROC21 at 14.67.

Exponential moving averages include EMA5 at ₹101.7, EMA10 at ₹101.8, EMA12 at ₹102.1, EMA20 at ₹102.2, EMA26 at ₹101.4, EMA50 at ₹98.2, EMA100 at ₹94.1, EMA200 at ₹81.8. Simple moving averages include SMA5 at ₹98.6, SMA10 at ₹99.6, SMA20 at ₹107.5, SMA30 at ₹99.8, SMA50 at ₹97.4, SMA100 at ₹89.6, SMA150 at ₹104.9, SMA200 at ₹86.5.

Support levels for CCME Global are placed at First Support ₹107.63, Second Support ₹107.37, Third Support ₹107.23. Resistance levels are seen at First Resistance ₹108.03, Second Resistance ₹108.17, Third Resistance ₹108.43. CCME Global Ltd. shareholding pattern shows promoter holding at 74.17%, FII holding at 0%, DII holding at 0%, public holding at 25.83%.

CCME Global Fundamentals

Market Cap

Below industry Median

140.30 Cr.

PE Ratio (TTM)

Negative PE TTM

-196.30

Dividend Yield

Net Profit TTM

120% decr over last year

-0.71

Net Profit Growth

120% decr over last year

-0.71

PEG Ratio

High in industry

1.60

ROE

104% decr over last year

-1.78

Operating Revenue TTM

Operating Revenue Growth

Book Value

High in industry

17.90

MFI

MFI is mid-range

57.82

RSI

RSI is mid-range

55.90

EPS (TTM)

-0.03

Debt to Equity

Face Value

Operating Profit Margin Qtr.

4.05

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

17.90

CCME Global Financials

Data not available for chart

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	0	0	0	0	0
Operating Expense	0.54	0.03	0.06	0.12	0.02
Operating Profit	-0.54	-0.03	-0.06	-0.12	-0.02
Depreciation	0	0	0	0	0
Interest	0	0	0	0	0
Tax	0	0	0	0	0
Net Profit	-0.50	-0.03	-0.06	-0.12	-0.02

CCME Global Technicals

CCME Global Ltd. EMA & SMA

₹107.90

5.10 (4.96%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹101.7

Day EMA10 ₹101.8

Day EMA12 ₹102.1

Day EMA20 ₹102.2

Day EMA26 ₹101.4

Day EMA50 ₹98.2

Day EMA100 ₹94.1

Day EMA200 ₹81.8

CCME Global Support and Resistance

Resistance

First Resistance₹108.03

Second Resistance₹108.17

Third Resistance₹108.43

Support

First Support₹107.63

Second Support₹107.37

Third Support₹107.23

Technical Indicators

Day RSI55.90

Day MFI57.82

Day ADX22.34

Day Commodity Channel Index3.10

William-50.40

Day MACD0.72

Day MACD Signal Line2.07

Day ATR5.64

Day ROC125-41.64

Day ROC2114.67

CCME Global Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	11.3	11.3	11.3	11.3	11.3	74.2
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	88.7	88.7	88.7	88.7	88.7	25.8

CCME Global Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	738	738	100.00%
Week	525	525	100.00%
1 Month	0	0	undefined%
6 Month	503	503	99.96%

CCME Global SWOT Analysis

Strengths14

Weakness5

Opportunity0

Threats0

Promoter holding increased more than 2% QoQ

Positive Breakout Third Resistance ( LTP > R3)

Companies with no Debt

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Rising Net Cash Flow and Cash from Operating activity

High Momentum Scores (Technical Scores greater than 50)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Top Gainers

CCME Global Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

CCME Global Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹44.60	₹570	₹201.65	₹268.50	₹36.72	₹6.05
% Change	-0.11%	N/A	-2.58%	-100.00%	-1.98%	-2.58%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	10.10	-	14.10	38.40	-86.90	-1.40
1 Year Return		45.89			716	506
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

AMANTA

Amanta Healthcare Ltd.

₹ 150.70

AHCL

Anlon Healthcare Ltd.

₹ 15.98

-0.56%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 87.03

-0.54%

APL

Asston Pharmaceuticals Ltd.

₹ 82.00

+5.13%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 535.50

-1.07%

ASTONEALAB

Astonea Labs Ltd.

₹ 255.20

-4.88%

AMWILL

Amwill Health Care Ltd.

₹ 45.19

+5.96%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 66.74

+1.26%

SHELTER

Shelter Pharma Ltd.

₹ 28.51

-1.72%

TLL

Trident Lifeline Ltd.

₹ 248.00

+0.63%

DPL

Dipna Pharmachem Ltd.

₹ 7.19

+0.00%

ACHYUT

Achyut Healthcare Ltd.

₹ 6.91

+3.13%

SIGACHI

Sigachi Industries Ltd.

₹ 21.60

+2.03%

WINDLAS

Windlas Biotech Ltd.

₹ 815.00

-1.71%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.15

+0.89%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 44.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 583.00

-1.04%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.44

-2.22%

ZIMLAB

Zim Laboratories Ltd.

₹ 108.50

-2.45%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1350.00

+3.84%

MEDICO

Medico Remedies Ltd.

₹ 42.99

+0.61%

SGRL

Shree Ganesh Remedies Ltd.

₹ 555.20

-1.13%

FAQ's on GENESIS

What is the Market Capitalization of CCME Global Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 28 April 2025, the market cap for CCME Global Ltd. is approximately ₹ 140.3 Cr.

What are the PE and PB ratios for CCME Global Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for CCME Global Ltd. is -196.3, and the Price-to-Book (PB) ratio is 17.9.

What is the 52-Week High and Low for CCME Global Ltd.?

Over the past 52 weeks, the highest price reached by CCME Global Ltd. shares was ₹ 184.9, and the lowest price was ₹ 21.22.

Who are the major shareholders of CCME Global Ltd.?

Significant shareholdings in CCME Global Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of CCME Global Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, CCME Global Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy